Global Prostate Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 20-Nov-2018
No. of pages: 117

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.

Scope of the Report:

The worldwide market for Prostate Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Prostate Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Tolmar

- Astellas Pharma

- AstraZeneca

- Ferring Pharmaceuticals

- Johnson & Johnson

- Abbott

- Sanofi

- Ipsen

- Novartis

- Bayer

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Enzalutamid

- Abiraterone

- Leuprolide

- Goserelin

- Triptorelin

- Histrelin

- Degarelix

- Sipuleucel-T

- Docetaxel

- Cabazitaxel

Market Segment by Applications, can be divided into

- Hospital

- Research Institution

- Clinic

- Drugstore

There are 15 Chapters to deeply display the global Prostate Cancer Treatment Drugs market.

Chapter 1, to describe Prostate Cancer Treatment Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Prostate Cancer Treatment Drugs, with sales, revenue, and price of Prostate Cancer Treatment Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Prostate Cancer Treatment Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Prostate Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Prostate Cancer Treatment Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Prostate Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Prostate Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Enzalutamid
1.2.2 Abiraterone
1.2.3 Leuprolide
1.2.4 Goserelin
1.2.5 Triptorelin
1.2.6 Histrelin
1.2.7 Degarelix
1.2.8 Sipuleucel-T
1.2.9 Docetaxel
1.2.10 Cabazitaxel
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Research Institution
1.3.3 Clinic
1.3.4 Drugstore
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Tolmar
2.1.1 Business Overview
2.1.2 Prostate Cancer Treatment Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Tolmar Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Astellas Pharma
2.2.1 Business Overview
2.2.2 Prostate Cancer Treatment Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Astellas Pharma Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Prostate Cancer Treatment Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ferring Pharmaceuticals
2.4.1 Business Overview
2.4.2 Prostate Cancer Treatment Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Prostate Cancer Treatment Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott
2.6.1 Business Overview
2.6.2 Prostate Cancer Treatment Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Prostate Cancer Treatment Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ipsen
2.8.1 Business Overview
2.8.2 Prostate Cancer Treatment Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ipsen Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis
2.9.1 Business Overview
2.9.2 Prostate Cancer Treatment Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bayer
2.10.1 Business Overview
2.10.2 Prostate Cancer Treatment Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bayer Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Prostate Cancer Treatment Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Prostate Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostate Cancer Treatment Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Prostate Cancer Treatment Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Prostate Cancer Treatment Drugs Market Analysis by Regions
4.1 Global Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Prostate Cancer Treatment Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.5 South America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5 North America Prostate Cancer Treatment Drugs by Countries
5.1 North America Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6 Europe Prostate Cancer Treatment Drugs by Countries
6.1 Europe Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.3 UK Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.4 France Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Prostate Cancer Treatment Drugs by Countries
7.1 Asia-Pacific Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.5 India Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8 South America Prostate Cancer Treatment Drugs by Countries
8.1 South America Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Prostate Cancer Treatment Drugs by Countries
9.1 Middle East and Africa Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
10 Global Prostate Cancer Treatment Drugs Market Segment by Type
10.1 Global Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Prostate Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
10.2 Enzalutamid Sales Growth and Price
10.2.1 Global Enzalutamid Sales Growth (2013-2018)
10.2.2 Global Enzalutamid Price (2013-2018)
10.3 Abiraterone Sales Growth and Price
10.3.1 Global Abiraterone Sales Growth (2013-2018)
10.3.2 Global Abiraterone Price (2013-2018)
10.4 Leuprolide Sales Growth and Price
10.4.1 Global Leuprolide Sales Growth (2013-2018)
10.4.2 Global Leuprolide Price (2013-2018)
10.5 Goserelin Sales Growth and Price
10.5.1 Global Goserelin Sales Growth (2013-2018)
10.5.2 Global Goserelin Price (2013-2018)
10.6 Triptorelin Sales Growth and Price
10.6.1 Global Triptorelin Sales Growth (2013-2018)
10.6.2 Global Triptorelin Price (2013-2018)
10.7 Histrelin Sales Growth and Price
10.7.1 Global Histrelin Sales Growth (2013-2018)
10.7.2 Global Histrelin Price (2013-2018)
10.8 Degarelix Sales Growth and Price
10.8.1 Global Degarelix Sales Growth (2013-2018)
10.8.2 Global Degarelix Price (2013-2018)
10.9 Sipuleucel-T Sales Growth and Price
10.9.1 Global Sipuleucel-T Sales Growth (2013-2018)
10.9.2 Global Sipuleucel-T Price (2013-2018)
10.10 Docetaxel Sales Growth and Price
10.10.1 Global Docetaxel Sales Growth (2013-2018)
10.10.2 Global Docetaxel Price (2013-2018)
10.11 Cabazitaxel Sales Growth and Price
10.11.1 Global Cabazitaxel Sales Growth (2013-2018)
10.11.2 Global Cabazitaxel Price (2013-2018)
11 Global Prostate Cancer Treatment Drugs Market Segment by Application
11.1 Global Prostate Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Research Institution Sales Growth (2013-2018)
11.4 Clinic Sales Growth (2013-2018)
11.5 Drugstore Sales Growth (2013-2018)
12 Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
12.1 Global Prostate Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Prostate Cancer Treatment Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.2 Europe Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.4 South America Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
12.3 Prostate Cancer Treatment Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Prostate Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Prostate Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)
12.4 Prostate Cancer Treatment Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Prostate Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Prostate Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Prostate Cancer Treatment Drugs Picture
Table Product Specifications of Prostate Cancer Treatment Drugs
Figure Global Sales Market Share of Prostate Cancer Treatment Drugs by Types in 2017
Table Prostate Cancer Treatment Drugs Types for Major Manufacturers
Figure Enzalutamid Picture
Figure Abiraterone Picture
Figure Leuprolide Picture
Figure Goserelin Picture
Figure Triptorelin Picture
Figure Histrelin Picture
Figure Degarelix Picture
Figure Sipuleucel-T Picture
Figure Docetaxel Picture
Figure Cabazitaxel Picture
Figure Prostate Cancer Treatment Drugs Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Research Institution Picture
Figure Clinic Picture
Figure Drugstore Picture
Figure United States Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Prostate Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Tolmar Basic Information, Manufacturing Base and Competitors
Table Tolmar Prostate Cancer Treatment Drugs Type and Applications
Table Tolmar Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Prostate Cancer Treatment Drugs Type and Applications
Table Astellas Pharma Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Prostate Cancer Treatment Drugs Type and Applications
Table AstraZeneca Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Type and Applications
Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Prostate Cancer Treatment Drugs Type and Applications
Table Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Prostate Cancer Treatment Drugs Type and Applications
Table Abbott Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Prostate Cancer Treatment Drugs Type and Applications
Table Sanofi Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Prostate Cancer Treatment Drugs Type and Applications
Table Ipsen Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Prostate Cancer Treatment Drugs Type and Applications
Table Novartis Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Prostate Cancer Treatment Drugs Type and Applications
Table Bayer Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Prostate Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Global Prostate Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Prostate Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Prostate Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales by Regions (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales Market Share by Regions (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue by Regions (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions in 2013
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions in 2017
Figure North America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure North America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table North America Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table North America Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Treatment Drugs Sales Market Share by Countries in 2013
Figure North America Prostate Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table North America Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2013
Figure North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure United States Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Canada Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Europe Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Europe Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Table Europe Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Germany Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure UK Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure France Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Russia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Italy Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Share by Countries 2017
Figure China Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Japan Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Korea Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure India Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table South America Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table South America Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table South America Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Brazil Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Prostate Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure UAE Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales Share by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue Share by Type (2013-2018)
Figure Global Enzalutamid Sales Growth (2013-2018)
Figure Global Enzalutamid Price (2013-2018)
Figure Global Abiraterone Sales Growth (2013-2018)
Figure Global Abiraterone Price (2013-2018)
Figure Global Leuprolide Sales Growth (2013-2018)
Figure Global Leuprolide Price (2013-2018)
Figure Global Goserelin Sales Growth (2013-2018)
Figure Global Goserelin Price (2013-2018)
Figure Global Triptorelin Sales Growth (2013-2018)
Figure Global Triptorelin Price (2013-2018)
Figure Global Histrelin Sales Growth (2013-2018)
Figure Global Histrelin Price (2013-2018)
Figure Global Degarelix Sales Growth (2013-2018)
Figure Global Degarelix Price (2013-2018)
Figure Global Sipuleucel-T Sales Growth (2013-2018)
Figure Global Sipuleucel-T Price (2013-2018)
Figure Global Docetaxel Sales Growth (2013-2018)
Figure Global Docetaxel Price (2013-2018)
Figure Global Cabazitaxel Sales Growth (2013-2018)
Figure Global Cabazitaxel Price (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales Share by Application (2013-2018)
Figure Global Research Institution Sales Growth (2013-2018)
Figure Global Clinic Sales Growth (2013-2018)
Figure Global Drugstore Sales Growth (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Prostate Cancer Treatment Drugs Sales Forecast by Regions (2018-2023)
Table Global Prostate Cancer Treatment Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Europe Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Figure South America Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Prostate Cancer Treatment Drugs Market Forecast (2018-2023)
Table Global Prostate Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
Table Global Prostate Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)
Table Global Prostate Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
Table Global Prostate Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cancer Monoclonal Antibodies Market 2018, Forecast to 2023
    Published: 14-Dec-2018        Price: US 4880 Onwards        Pages: 119
    The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics. Scope of the Report: This report focuses on the Cancer Monoclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, Sou......
  • Global and Chinese Syphilis Rapid Test Kit Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 150
    The 'Global and Chinese Syphilis Rapid Test Kit Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Syphilis Rapid Test Kit industry with a focus on the Chinese market. The report provides key statistics on the market status of the Syphilis Rapid Test Kit manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the indu......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cervical Cancer Drugs Market 2018, Forecast to 2023
    Published: 14-Dec-2018        Price: US 4880 Onwards        Pages: 130
    Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic pain, pain during sexual intercourse, and abnormal vaginal discharge. Scope of the Report: This report focuses on the Cervical Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and ap......
  • Global and Chinese Human Growth Hormone Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Human Growth Hormone Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Human Growth Hormone industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Growth Hormone manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry incl......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Chlorpheniramine Maleate Market 2018, Forecast to 2023
    Published: 14-Dec-2018        Price: US 4880 Onwards        Pages: 128
    Chlorpheniramine maleate is an alkylamine antihistamine which is used in the treatment of allergic conditions such as rhinitis and urticaria. Scope of the Report: This report focuses on the Chlorpheniramine Maleate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. This compound blocks histamine during allergic reaction......
  • Global and Chinese Active Pharmaceutical Ingredients Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 146
    The 'Global and Chinese Active Pharmaceutical Ingredients Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Active Pharmaceutical Ingredients industry with a focus on the Chinese market. The report provides key statistics on the market status of the Active Pharmaceutical Ingredients manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provide......
  • Global and Chinese Acyclovir Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Acyclovir Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Acyclovir industry with a focus on the Chinese market. The report provides key statistics on the market status of the Acyclovir manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, application......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cetrimide Market 2018, Forecast to 2023
    Published: 14-Dec-2018        Price: US 4880 Onwards        Pages: 137
    Cetrimide is an antiseptic agent, meaning it has various antibacterial, antifungal and other antimicrobial properties and can be applied to skin or mucous membranes to avoid or minimize the risk of infection. It is also a surfactant, meaning it functions as a detergent with cleaning properties. Scope of the Report: This report focuses on the Cetrimide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ......
  • Global and Chinese Bone Glues Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Bone Glues Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Bone Glues industry with a focus on the Chinese market. The report provides key statistics on the market status of the Bone Glues manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applicat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs